跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11 条关于
“ORZEYFUL (oveporexton)”
全部
11
临床试验
1
药物
1
机构
0
资讯
9
9天前
FDA Approves Orzeyful (oveporexton), First Orexin Agonist for Narcolepsy Type 1
3个月前
Takeda Reports Solid Q1 FY2026 Results, Secures First Approval for Narcolepsy Drug ORZEYFUL in China
9天前
NEJM Publishes Phase 3 Data for Takeda's Oveporexton, the First Approved Orexin Agonist for Narcolepsy Type 1
9个月前
Experimental Narcolepsy Drug Oveporexton Shows Cognitive Benefits in Phase 2 Trial
去年
Takeda's Oveporexton Shows Promising Results in Phase 2b Trial for Narcolepsy Type 1
上个月
Orexin Receptor Agonists Herald a New Era for Narcolepsy Type 1 Treatment
去年
Takeda Highlights Late-Stage Pipeline with Potential Blockbuster Drugs
11个月前
Alkermes Acquires Avadel for Up to $2.1B to Accelerate Sleep Medicine Market Entry
5个月前
Takeda Announces Major Restructuring with 247 Job Cuts in Massachusetts to Fund Late-Stage Pipeline